A proposed protocol of derived mesenchymal stem cells for the treatment of COVID-19 patients

Cell & Gene Therapy Insights 2020; 6(6), 807–811


Published: 10 July 2020
Preliminary Communication
Vasiliki Kalodimou, Alma Reyes-Calavera

Recent reports have shown that mesenchymal stem cells (MSC) could be used for transplantation in various diseases. Mesenchymal stem cells exhibit remarkable plasticity and harbor potential for use in therapeutic applications while mesenchymal stem cell research could lead to many therapies becoming available to treat or repair injured or diseased tissues in a range of diseases, such as COVID-19-related pneumonia.